4//SEC Filing
DUNCAN MICHAEL R 4
Accession 0001252998-04-000005
CIK 0000809875other
Filed
Oct 18, 8:00 PM ET
Accepted
Oct 19, 4:54 PM ET
Size
14.0 KB
Accession
0001252998-04-000005
Insider Transaction Report
Form 4
DUNCAN MICHAEL R
VP and General Manager
Transactions
- Sale
Common Stock, $.001 Par Value
2004-10-18$30.14/sh−4,200$126,567→ 715 total - Exercise/Conversion
Common Stock, $.001 Par Value
2004-10-18$10.13/sh+4,200$42,525→ 4,915 total - Exercise/Conversion
Stock Option (Right-To-Buy)
2004-10-18$10.13/sh−4,200$42,525→ 0 totalExercise: $10.13From: 1999-11-13Exp: 2008-11-13→ Common Stock (4,200 underlying) - Exercise/Conversion
Stock Option (Right-To-Buy)
2004-10-18$9.75/sh−800$7,800→ 19,200 totalExercise: $9.75From: 2000-11-15Exp: 2009-11-15→ Common Stock (800 underlying) - Exercise/Conversion
Common Stock, $.001 Par Value
2004-10-18$9.75/sh+800$7,800→ 1,515 total - Sale
Common Stock, $.001 Par Value
2004-10-18$30.14/sh−800$24,108→ 715 total
Footnotes (1)
- [F1]The stock option exercise and sale reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
Documents
Issuer
ATRIX LABORATORIES INC
CIK 0000809875
Entity typeother
Related Parties
1- filerCIK 0001252998
Filing Metadata
- Form type
- 4
- Filed
- Oct 18, 8:00 PM ET
- Accepted
- Oct 19, 4:54 PM ET
- Size
- 14.0 KB